October 8, 2013
For our latest podcast about entrepreneurship in synthetic biology, we spoke with Jason Kelly, co-founder of Ginkgo BioWorks. Boston-based Ginkgo uses an integrated engineering platform to design made-to-order microbes for customers working in pharmaceuticals, flavorings and other fields. (See the company’s own highly entertaining video here.)
In the interview, Kelly talks about how technologies are quickly making it easier to engineer bio-organisms, leading towards greater disruption – and that a key challenge for Gingko is educating customers about these changes. Kelly spoke with us between sessions at the SynBioBeta conference in Silicon Valley in November 2012.